Fejleh M Phillip, Chang Michael, Anand Gobind, Savides Thomas J
Division of Gastroenterology, Department of Medicine, University of California San Diego, USA (M. Phillip Fejleh, Michael Chang, Gobind Anand, Thomas J. Savides).
Ann Gastroenterol. 2022 Mar-Apr;35(2):177-181. doi: 10.20524/aog.2022.0694. Epub 2022 Jan 7.
Treatment options for malignant bowel obstruction are limited, particularly in poor surgical candidates. Standard percutaneous endoscopic gastrostomy (PEG) tubes used for venting are of small caliber, limiting success. This study examines outcomes in patients who received larger-caliber 30-Fr PEGs for treatment of malignant bowel obstruction.
Retrospective chart review for all patients who received a large-caliber venting PEGs for malignant bowel obstruction in a series of patients at a single institution.
Thirty-six patients were included. The most common primary cancer diagnoses were ovarian (22%), mucinous appendiceal (19%), and colorectal (17%). Symptom relief was achieved in all patients (100%). Four patients (11%) sought medical care for recurrent symptoms due to an incorrect venting technique. Large-caliber venting PEGs were placed on the first admission for obstruction in 17 patients (47%), and were used to replace standard caliber PEGs in 8 patients because of persistent symptoms (22%). Significant ascites was observed in 12 patients (33%), but paracenteses were performed in only 3 of these patients prior to PEG placement. Most large-caliber venting PEGs were placed during hospital admission (34/36, 94%), and facilitated hospital discharge (33/34, 97%). Two significant (6%) and 2 minor adverse events (6%) occurred.
This study demonstrates the efficacy and safety of large-caliber venting PEGs for malignant bowel obstruction. This facilitated hospital discharge in almost all patients and prevented readmissions when a correct venting technique was utilized; these PEGs were also effective in patients who had failed standard PEG tube venting.
恶性肠梗阻的治疗选择有限,尤其是对于手术风险高的患者。用于排气的标准经皮内镜下胃造口术(PEG)管管径较小,成功率有限。本研究探讨了接受较大管径(30F)PEG管治疗恶性肠梗阻患者的治疗效果。
对在单一机构接受较大管径排气PEG管治疗恶性肠梗阻的所有患者进行回顾性病历审查。
共纳入36例患者。最常见的原发性癌症诊断为卵巢癌(22%)、黏液性阑尾癌(19%)和结直肠癌(17%)。所有患者(100%)均实现症状缓解。4例患者(11%)因排气技术不正确出现复发症状而就医。17例患者(47%)在首次因肠梗阻入院时放置了较大管径的排气PEG管,8例患者(22%)因症状持续而用其替换了标准管径的PEG管。12例患者(33%)出现大量腹水,但仅3例患者在放置PEG管前进行了腹腔穿刺引流。大多数较大管径的排气PEG管在住院期间放置(34/36,94%),并有助于患者出院(33/34,97%)。发生了2例严重不良事件(6%)和2例轻微不良事件(6%)。
本研究证明了较大管径排气PEG管治疗恶性肠梗阻的有效性和安全性。这几乎使所有患者都能顺利出院,并在采用正确排气技术时防止再次入院;这些PEG管对标准PEG管排气失败的患者也有效。